taurine has been researched along with Kidney Failure, Chronic in 27 studies
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment." | 9.14 | A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. ( Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D, 2010) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 5.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "Taurolidine-citrate use did not decrease all-cause bacteremia and was associated with a greater need for thrombolytic treatment." | 5.14 | A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis. ( Al-Sayed, T; Bhat, R; Cheesbrough, JS; Curry, A; Diggle, P; Ebah, L; Heap, M; Millband, N; Mitra, S; Saxena, R; Schulz, M; Solomon, LR; Waterhouse, D, 2010) |
| "The incidence and cost of treatment of catheter sepsis occurring in all patients receiving haemodialysis via a line were investigated over 6-month periods before and after introducing the taurolidine/citrate line-locking agent." | 5.13 | A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients. ( Cahill, J; Gerrish, M; Little, J; Taylor, C, 2008) |
| "Taurolidine is a non-antibiotic antimicrobial, with broad bactericidal and fungicidal properties." | 1.37 | Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis. ( Chiarelli, G; Cozzolino, M; Cusi, D; Gallieni, M; Olivi, L, 2011) |
| "Thirty-seven ESRD patients (24 males, 13 females) on dialysis treatment (18 haemodialysis, 19 continuous ambulatory peritoneal dialysis) and 21 healthy subjects (seven males, 14 females) were examined." | 1.31 | Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease. ( Anderstam, B; Bárány, P; Bergström, J; Divino Filho, JC; Heimbürger, O; Lindholm, B; Qureshi, AR; Stenvinkel, P; Suliman, ME, 2002) |
| "Thus, vitamin B6 deficiency in chronically uremic rats administered with large amounts of methionine may reduce growth, lower renal function and cause abnormal metabolism of sulfur-containing amino acids." | 1.29 | Content of sulfur amino acids and vitamin B6 and related enzyme activities in rats with chronic renal failure fed a high methionine diet. ( Asagi, K; Awata, S; Kobayashi, M; Kodama, H; Nakayama, K; Nakayama, M, 1996) |
| "Thus, both chronic renal failure and a routine hemodialysis treatment produce changes in cell and plasma taurine levels that tend to be specific for the individual cell type." | 1.28 | Taurine levels in plasma and blood cells in patients undergoing routine maintenance hemodialysis. ( Jung, BC; Kopple, JD; Laidlaw, SA, 1991) |
| "Methionine levels were not different but there were significant increases in cystine (P less than 0." | 1.26 | Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide. ( Gupta, VJ; Wilcken, DE, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (18.52) | 18.7374 |
| 1990's | 8 (29.63) | 18.2507 |
| 2000's | 5 (18.52) | 29.6817 |
| 2010's | 7 (25.93) | 24.3611 |
| 2020's | 2 (7.41) | 2.80 |
| Authors | Studies |
|---|---|
| Sengupta, P | 1 |
| Biswas, S | 1 |
| Roy, T | 1 |
| Post, A | 1 |
| Kremer, D | 1 |
| Groothof, D | 1 |
| van der Veen, Y | 1 |
| de Blaauw, P | 1 |
| van der Krogt, J | 1 |
| Kema, IP | 1 |
| Westerhuis, R | 1 |
| Heiner-Fokkema, MR | 1 |
| Bakker, SJL | 1 |
| Franssen, CFM | 1 |
| Kyriakopoulos, AM | 1 |
| Grapsa, E | 1 |
| Marcinkiewicz, J | 1 |
| Nagl, M | 1 |
| Fontseré, N | 1 |
| Cardozo, C | 1 |
| Donate, J | 1 |
| Soriano, A | 1 |
| Muros, M | 1 |
| Pons, M | 1 |
| Mensa, J | 1 |
| Campistol, JM | 1 |
| Navarro-González, JF | 1 |
| Maduell, F | 1 |
| Taylor, C | 1 |
| Cahill, J | 1 |
| Gerrish, M | 1 |
| Little, J | 1 |
| Solomon, LR | 1 |
| Cheesbrough, JS | 1 |
| Ebah, L | 1 |
| Al-Sayed, T | 1 |
| Heap, M | 1 |
| Millband, N | 1 |
| Waterhouse, D | 1 |
| Mitra, S | 1 |
| Curry, A | 1 |
| Saxena, R | 1 |
| Bhat, R | 1 |
| Schulz, M | 1 |
| Diggle, P | 1 |
| Gallieni, M | 1 |
| Chiarelli, G | 1 |
| Olivi, L | 1 |
| Cozzolino, M | 1 |
| Cusi, D | 1 |
| Filiopoulos, V | 1 |
| Hadjiyannakos, D | 1 |
| Koutis, I | 1 |
| Trompouki, S | 1 |
| Micha, T | 1 |
| Lazarou, D | 1 |
| Vlassopoulos, D | 1 |
| Branger, B | 1 |
| Reboul, P | 1 |
| Prelipcean, C | 1 |
| Noguera, ME | 1 |
| Cariou, S | 1 |
| Granolleras, C | 1 |
| Vecina, F | 1 |
| Zabadani, B | 1 |
| Boubenider, S | 1 |
| Rousseau, P | 1 |
| Deshodt, G | 1 |
| Ramperez, P | 1 |
| Hory, B | 1 |
| Picard, E | 1 |
| Branchereau, P | 1 |
| Fabbro-Peray, P | 1 |
| Fourcade, J | 1 |
| Zinellu, A | 1 |
| Sotgia, S | 1 |
| Loriga, G | 1 |
| Deiana, L | 1 |
| Satta, AE | 1 |
| Carru, C | 1 |
| Law, RO | 1 |
| Michalk, DV | 4 |
| Essich, HJ | 1 |
| Böhles, HJ | 2 |
| Schärer, K | 2 |
| Smith, CA | 1 |
| Qureshi, GA | 1 |
| Baig, SM | 1 |
| Asagi, K | 1 |
| Nakayama, M | 1 |
| Kobayashi, M | 1 |
| Awata, S | 1 |
| Nakayama, K | 1 |
| Kodama, H | 1 |
| Suliman, ME | 3 |
| Anderstam, B | 2 |
| Bergström, J | 4 |
| Sodemann, K | 1 |
| Polaschegg, HD | 1 |
| Feldmer, B | 1 |
| Bárány, P | 2 |
| Filho, JC | 1 |
| Lindholm, B | 3 |
| Divino Filho, JC | 1 |
| Qureshi, AR | 1 |
| Stenvinkel, P | 1 |
| Heimbürger, O | 1 |
| Wilcken, DE | 1 |
| Gupta, VJ | 1 |
| Dow, SW | 1 |
| Fettman, MJ | 1 |
| Jung, BC | 1 |
| Laidlaw, SA | 1 |
| Kopple, JD | 1 |
| Leitz, R | 1 |
| Rauch, J | 1 |
| Bocock, MA | 1 |
| Zlotkin, SH | 1 |
| Alvestrand, A | 1 |
| Fürst, P | 1 |
| Enzner, G | 1 |
| Seider, R | 1 |
| Böhles, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective, Randomized, Controlled Trial Evaluating the Efficacy of a Lock-therapy With a Solution of Taurolidine/Citrate (TauroLock) vs Standard Saline Solution for the Primary Prevention of Catheter-related Infections (CLI) in Adult Patients Wtih a Non[NCT02279121] | 162 participants (Actual) | Interventional | 2014-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for taurine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Chronic renal disease and potassium depletion in cats.
Topics: Animals; Cat Diseases; Cats; Kidney Failure, Chronic; Potassium; Potassium Deficiency; Taurine | 1992 |
8 trials available for taurine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Comparative Study to Evaluate the Effect of Low-Protein Diet Supplementation with Taurine and N-Acetylcysteine, N-Acetylcysteine and Pyridoxamine Dihydrochloride in Preventing the Progression of Chronic Renal Failure in Patients with Non-Diabetic Kidney D
Topics: Acetylcysteine; Adult; Aged; Diet, Protein-Restricted; Dietary Supplements; Disease Progression; Fem | 2022 |
A new haemodialysis catheter-locking agent reduces infections in haemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Local; Catheters, Indwelling; Chi-Square Dist | 2008 |
A randomized double-blind controlled trial of taurolidine-citrate catheter locks for the prevention of bacteremia in patients treated with hemodialysis.
Topics: Adult; Aged; Anti-Infective Agents; Anticoagulants; Bacteremia; Catheters, Indwelling; Citric Acid; | 2010 |
Approaches to prolong the use of uncuffed hemodialysis catheters: results of a randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Anticoagulants; Catheter-Related Infections; | 2011 |
[Tunnelled internal jugular vein catheters with taurolidine lock: an acceptable challenge to arterio-venous fistula in 70 years old haemodialyzed patients: a prospective pilot study].
Topics: Aged; Anti-Infective Agents, Local; Arteriovenous Shunt, Surgical; Catheterization, Central Venous; | 2011 |
Oxidative stress improvement is associated with increased levels of taurine in CKD patients undergoing lipid-lowering therapy.
Topics: Aged; Allantoin; Azetidines; Drug Administration Schedule; Drug Combinations; Ezetimibe; Female; Hum | 2012 |
Evidence of taurine depletion and accumulation of cysteinesulfinic acid in chronic dialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acids, Branched-Chain; Amino Acids, Sulfur; Animal | 1996 |
Accumulation of taurine in patients with renal failure.
Topics: Contraindications; Dizziness; Humans; Kidney Failure, Chronic; Renal Dialysis; Taurine | 2002 |
18 other studies available for taurine and Kidney Failure, Chronic
| Article | Year |
|---|---|
Amino Acid Homeostasis and Fatigue in Chronic Hemodialysis Patients.
Topics: Amino Acids; Fatigue; Female; Homeostasis; Humans; Kidney Failure, Chronic; Male; Renal Dialysis; Ta | 2022 |
Swift Cure of a Chronic Wound Infected With Multiresistant
Topics: Administration, Topical; Aged, 80 and over; Anti-Infective Agents; Anti-Inflammatory Agents; Chronic | 2019 |
Tunneled catheters with taurolidine-citrate-heparin lock solution significantly improve the inflammatory profile of hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticoagulants; C-Reactive Protein; Catheter- | 2014 |
Unsuccessful application of taurolidine in the treatment of fungal peritonitis in peritoneal dialysis.
Topics: Adult; Antifungal Agents; Candidiasis; Catheter-Related Infections; Catheters, Indwelling; Device Re | 2011 |
The mechanisms of taurine's protective action against acute guanidino neurotoxicity.
Topics: Animals; Antioxidants; Cell Size; Cytoprotection; Guanidines; Kidney Failure, Chronic; Rats; Taurine | 2006 |
Taurine metabolism in experimental renal failure.
Topics: Acute Kidney Injury; Animals; Brain; Creatinine; Kidney Failure, Chronic; Liver; Male; Muscles; Myoc | 1983 |
Growth, taurine, and calcium metabolism in chronic renal failure: effect of taurine and methionine deficiency.
Topics: Animals; Blood Urea Nitrogen; Calcium; Creatine; Eating; Growth; Kidney Failure, Chronic; Male; Meth | 1983 |
Changes and challenges in feline nutrition.
Topics: Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Cat Diseases; Cats; Diabetes Melli | 1993 |
Application of high performance liquid chromatography in study of sulphur amino acid metabolism in uremic patients.
Topics: Aged; Cysteine; Female; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Muscles; Per | 1993 |
Content of sulfur amino acids and vitamin B6 and related enzyme activities in rats with chronic renal failure fed a high methionine diet.
Topics: Amino Acids, Sulfur; Animals; Blood Urea Nitrogen; Body Weight; Creatinine; Cystathionine; Cystathio | 1996 |
Two years' experience with Dialock and CLS (a new antimicrobial lock solution).
Topics: Adult; Anti-Infective Agents; Anticoagulants; Catheterization, Central Venous; Catheters, Indwelling | 2001 |
Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease.
Topics: Adult; Cysteine; Dipeptides; Erythrocytes; Female; Glutathione; Humans; Kidney Failure, Chronic; Mal | 2002 |
Sulphr containing amino acids in chronic renal failure with particular reference to homocystine and cysteine-homocysteine mixed disulphide.
Topics: Amino Acids, Sulfur; Creatinine; Cysteine; Cystine; Dipeptides; Disulfides; Female; Homocysteine; Hu | 1979 |
Taurine levels in plasma and blood cells in patients undergoing routine maintenance hemodialysis.
Topics: Adult; Blood Platelets; Erythrocytes; Granulocytes; Humans; Kidney Failure, Chronic; Lymphocytes; Mi | 1991 |
Influence of dietary sulfur-containing amino acids on renal function and metabolism of calcium and taurine in chronic renal failure.
Topics: Amino Acids, Sulfur; Animal Feed; Animals; Biometry; Calcium; Kidney; Kidney Failure, Chronic; Male; | 1990 |
Hepatic sulfur amino acid metabolism in rats with chronic renal failure.
Topics: Amino Acids, Sulfur; Animals; Anorexia; Creatinine; Cystathionine beta-Synthase; Cystathionine gamma | 1990 |
Sulphur amino acids in plasma and muscle in patients with chronic renal failure: evidence for taurine depletion.
Topics: Adult; Aged; Amino Acids, Sulfur; Cysteine; Female; Humans; Kidney Failure, Chronic; Male; Methionin | 1989 |
Effect of taurine on cardiovascular disturbances in rats with chronic renal failure.
Topics: Animals; Blood Pressure; Calcium; Cardiovascular Diseases; Electrocardiography; Kidney Failure, Chro | 1985 |